CATALAYER NEWS
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Source: Bloomberg Markets · 2026-09-24
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
MORE FROM BLOOMBERG MARKETS
AI Boom Can Withstand Higher Rates: Goldman's Moe
2026-09-25
Lula to Ban Online Betting, Offer Debt Relief Before Election
2026-09-25
Gold Tilts Lower as Iran Impasse Continues to Fan Rate-Hike Bets
2026-09-24
Xi Urges AI Cooperation WIth US
2026-09-24
De olho nas eleições no Brasil
2026-09-24
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets